09:54 AM EST - Medexus Pharmaceuticals : Announced preliminary revenue estimates for the company’s fourth fiscal quarter and full fiscal year ended March 31, 2023. Annual revenue is expected to exceed US$107 million for fiscal year ended March 31, 2023, an all-time record, including fiscal Q4 2023 revenue of at least US$28 million. Medexus Pharmaceuticals
shares T.MDP are trading up $0.10 at $1.69.
